- Home
- ASND vs SUZ Comparison
ASND vs SUZ Comparison
Compare ASND & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | SUZ |
|---|---|---|
| Founded | 2006 | 1924 |
| Country | Denmark | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 10.8B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASND | SUZ |
|---|---|---|
| Price | $213.03 | $9.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $256.40 | N/A |
| AVG Volume (30 Days) | 708.6K | ★ 2.7M |
| Earning Date | 02-11-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.93% |
| EPS Growth | N/A | ★ 61.72 |
| EPS | N/A | ★ 0.99 |
| Revenue | $758,592,045.00 | ★ $9,603,137,110.00 |
| Revenue This Year | $98.90 | $7.05 |
| Revenue Next Year | $83.74 | $12.79 |
| P/E Ratio | ★ N/A | $9.59 |
| Revenue Growth | ★ 97.46 | 17.39 |
| 52 Week Low | $118.03 | $8.41 |
| 52 Week High | $229.94 | $10.86 |
Technical Indicators
Market Signals| Indicator | ASND | SUZ |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 53.93 |
| Support Level | $207.28 | $9.31 |
| Resistance Level | $215.98 | $9.40 |
| Average True Range (ATR) | 7.22 | 0.17 |
| MACD | 0.49 | 0.01 |
| Stochastic Oscillator | 62.98 | 56.40 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.